Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/29 | Not Applicable | Not yet recruiting | |||
2024/10/15 | Phase 1 | Not yet recruiting | |||
2022/03/02 | Phase 3 | Completed | |||
2022/02/24 | Phase 3 | Completed | |||
2022/02/24 | Phase 3 | Completed | |||
2020/04/24 | Phase 2 | Completed | |||
2019/11/22 | Phase 2 | Completed | |||
2019/11/19 | Phase 1 | Completed | |||
2019/05/01 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Ebronucimab Injection | 国药准字S20240042 | 生物制品 | 注射剂 | 9/26/2024 | |
| Ebronucimab Injection | 国药准字S20240041 | 生物制品 | 注射剂 | 9/26/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.